Does midbrain urocortin 1 matter? A 15-year journey from stress (mal)adaptation to energy metabolism

References

• Asakawa A, Inui A, Ueno N, Makino S, Fujino MA, Kasuga M. 1999. Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology. 116 6: 1287–1292.
   PubMed Web of Science ®Google Scholar
• Asakawa A, Inui A, Ueno N, Makino S, Fujimiya M, Fujino MA, Kasuga M. 2001. Urocortin reduces oxygen consumption in lean and ob/ob mice. Int J Mol Med. 7 5: 539–541.
   PubMedGoogle Scholar
• Bale TL. 2006. Stress sensitivity and the development of affective disorders. Horm Behav. 50 4: 529–533.
   PubMed Web of Science ®Google Scholar
• Bale TL, Vale WW. 2004. CRF and CRF receptors: Role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol. 44:525–557.
   PubMed Web of Science ®Google Scholar
• Bittencourt JC, Sawchenko PE. 2000. Do centrally administered neuropeptides access cognate receptors?: An analysis in the central corticotropin-releasing factor system. J Neurosci. 20 3: 1142–1156.
   PubMedGoogle Scholar
• Bittencourt JC, Vaughan J, Arias C, Rissman RA, Vale WW, Sawchenko PE. 1999. Urocortin expression in rat brain: Evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol. 415 3: 285–312.
   PubMed Web of Science ®Google Scholar
• Ciccocioppo R, Gehlert DR, Ryabinin A, Kaur S, Cippitelli A, Thorsell A, Le AD, Hipskind PA, Hamdouchi C, Lu J, Hembre EJ, Cramer J, Song M, McKinzie D, Morin M, Economidou D, Stopponi S, Cannella N, Braconi S, Kallupi M, de GG, Massi M, George DT, Gilman J, Hersh J, Tauscher JT, Hunt SP, Hommer D, Heilig M. 2009. Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond. Alcohol. 43 7: 491–498.
   PubMedGoogle Scholar
• Comuzzie AG, Hixson JE, Almasy L, Mitchell BD, Mahaney MC, Dyer TD, Stern MP, MacCluer JW, Blangero J. 1997. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet. 15 3: 273–276.
   PubMedGoogle Scholar
• Cunha RP, Reiner A, Toledo CA. 2007. Involvement of urocortinergic neurons below the midbrain central gray in the physiological response to restraint stress in pigeons. Brain Res. 1147:175–183.
   PubMedGoogle Scholar
• de Kloet ER, Joels M, Holsboer F. 2005. Stress and the brain: From adaptation to disease. Nat Rev Neurosci. 6 6: 463–475.
   PubMed Web of Science ®Google Scholar
• Delplanque J, Vasseur F, Durand E, Abderrahmani A, Dina C, Waeber G, Guy-Grand B, Clement K, Weill J, Boutin P, Froguel P. 2002. Mutation screening of the urocortin gene: Identification of new single nucleotide polymorphisms and association studies with obesity in French Caucasians. J Clin Endocrinol Metab. 87 2: 867–869.
   PubMedGoogle Scholar
• Derks NM. 2010. The role of the non-preganglionic Edinger–Westphal nucleus in sex-dependent stress adaptation in rodents Donders Series. Nijmegen: PrintPartners Ipskamp.
   Google Scholar
• Derks NM, Roubos EW, Kozicz T. 2007. Presence of estrogen receptor beta in urocortin 1-neurons in the mouse non-preganglionic Edinger–Westphal nucleus. Gen Comp Endocrinol. 153 1–3: 228–234.
   PubMedGoogle Scholar
• Derks NM, Gaszner B, Roubos EW, Kozicz LT. 2009. Sex differences in urocortin 1 dynamics in the non-preganglionic Edinger–Westphal nucleus of the rat. Neurosci Res. 66 1: 117–123.
   PubMedGoogle Scholar
• Eckart K, Radulovic J, Radulovic M, Jahn O, Blank T, Stiedl O, Spiess J. 1999. Actions of CRF and its analogs. Curr Med Chem. 6 11: 1035–1053.
   PubMedGoogle Scholar
• Fatima A, Haroon MF, Wolf G, Engelmann M, Spina MG. 2007. Reduced urocortin 1 immunoreactivity in the non-preganglionic Edinger–Westphal nucleus during late pregnancy in rats. Regul Pept. 143 1–3: 34–38.
   PubMedGoogle Scholar
• Fonareva I, Spangler E, Cannella N, Sabino V, Cottone P, Ciccocioppo R, Zorrilla EP, Ryabinin AE. 2009. Increased perioculomotor urocortin 1 immunoreactivity in genetically selected alcohol preferring rats. Alcohol Clin Exp Res. 33 11: 1956–1965.
   PubMedGoogle Scholar
• Frackiewicz EJ, Sramek JJ, Cutler NR. 2000. Gender differences in depression and antidepressant pharmacokinetics and adverse events. Ann Pharmacother. 34 1: 80–88.
   PubMed Web of Science ®Google Scholar
• Gaszner B, Csernus V, Kozicz T. 2004. Urocortinergic neurons respond in a differentiated manner to various acute stressors in the Edinger–Westphal nucleus in the rat. J Comp Neurol. 480 2: 170–179.
   PubMedGoogle Scholar
• Gaszner B, Korosi A, Palkovits M, Roubos EW, Kozicz T. 2007. Neuropeptide Y activates urocortin 1 neurons in the nonpreganglionic Edinger–Westphal nucleus. J Comp Neurol. 500 4: 708–719.
   PubMedGoogle Scholar
• Gaszner B, Van Wijk DC, Korosi A, Jozsa R, Roubos EW, Kozicz T. 2009. Diurnal expression of period 2 and urocortin 1 in neurones of the non-preganglionic Edinger–Westphal nucleus in the rat. Stress. 12 2: 115–124.
   PubMed Web of Science ®Google Scholar
• Gysling K, Forray MI, Haeger P, Daza C, Rojas R. 2004. Corticotropin-releasing hormone and urocortin: Redundant or distinctive functions?. Brain Res Brain Res Rev. 47 1–3: 116–125.
   PubMedGoogle Scholar
• Haeger P, Andres ME, Forray MI, Daza C, Araneda S, Gysling K. 2006. Estrogen receptors alpha and beta differentially regulate the transcriptional activity of the Urocortin gene. J Neurosci. 26 18: 4908–4916.
   PubMedGoogle Scholar
• Hauger RL, Risbrough V, Brauns O, Dautzenberg FM. 2006. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: New molecular targets. CNS Neurol Disord Drug Targets. 5 4: 453–479.
   PubMedGoogle Scholar
• Herman JP, Adams D, Prewitt C. 1995. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology. 61 2: 180–190.
   PubMedGoogle Scholar
• Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, Cullinan WE. 2003. Central mechanisms of stress integration: Hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol. 24 3: 151–180.
   PubMed Web of Science ®Google Scholar
• Holsboer F, Gerken A, Steiger A, Benkert O, Muller OA, Stalla GK. 1984. Corticotropin-releasing-factor induced pituitary-adrenal response in depression. Lancet. 1 8367: 55.
   PubMedGoogle Scholar
• Iino K, Sasano H, Oki Y, Andoh N, Shin RW, Kitamoto T, Takahashi K, Suzuki H, Tezuka F, Yoshimi T, Nagura H. 1999. Urocortin expression in the human central nervous system. Clin Endocrinol (Oxf). 50 1: 107–114.
   PubMedGoogle Scholar
• Joels M, Baram TZ. 2009. The neuro-symphony of stress. Nat Rev Neurosci. 10 6: 459–466.
   PubMed Web of Science ®Google Scholar
• Kaur S, Ryabinin AE. 2010. Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortin-containing neurons. Alcohol Clin Exp Res. 34 9: 1525–1534.
   PubMed Web of Science ®Google Scholar
• Kinney JW, Scruggs B, Avery DD. 2001. Peripheral administration of urocortin suppresses operant responding for food reward. Peptides. 22 4: 583–587.
   PubMedGoogle Scholar
• Koolhaas JM, Everts H, de Ruiter AJ, De Boer SF, Bohus B. 1998. Coping with stress in rats and mice: Differential peptidergic modulation of the amygdala-lateral septum complex. Prog Brain Res. 119:437–448.
   PubMedGoogle Scholar
• Korosi A, Schotanus S, Olivier B, Roubos EW, Kozicz T. 2005. Chronic ether stress-induced response of urocortin 1 neurons in the Edinger–Westphal nucleus in the mouse. Brain Res. 1046 1–2: 172–179.
   PubMedGoogle Scholar
• Kornstein SG. 1997. Gender differences in depression: implications for treatment. J Clin Psychiatry 58 Suppl. 15:12–8.
   Google Scholar
• Kotz CM, Wang C, Levine AS, Billington CJ. 2002. Urocortin in the hypothalamic PVN increases leptin and affects uncoupling proteins-1 and -3 in rats. Am J Physiol Regul Integr Comp Physiol. 282 2: R546–R551.
   Google Scholar
• Kozicz T. 2007. On the role of urocortin 1 in the non-preganglionic Edinger–Westphal nucleus in stress adaptation. Gen Comp Endocrinol. 153 1–3: 235–240.
   PubMedGoogle Scholar
• Kozicz T. 2009. Neurobiology of corticotropin releasing factor system components in stress; from adaptation to maladaptation. In: Kovacs M, Merchenthaler I. editors. Neuropeptides and peptide analogs. Kerala, India: Research Signpost. p 59–90.
   Google Scholar
• Kozicz T. 2010. The missing link; the significance of urocortin 1/urocortin 2 in the modulation of the dorsal raphe serotoninergic system. Mol Psychiatry. 15 4: 340–341.
   PubMedGoogle Scholar
• Kozicz T, Yanaihara H, Arimura A. 1998. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol. 391 1: 1–10.
   PubMedGoogle Scholar
• Kozicz T, Min L, Arimura A. 2001. The activation of urocortin immunoreactive neurons in the Edinger–Westphal nucelus following acute pain stress in rats. Stress. 4:85–90.
   PubMedGoogle Scholar
• Kozicz T, Arimura A, Maderdrut JL, Lazar G. 2002. Distribution of urocortin-like immunoreactivity in the central nervous system of the frog Rana esculenta. J Comp Neurol. 453 2: 185–198.
   PubMedGoogle Scholar
• Kozicz T, Tilburg-Ouwens D, Faludi G, Palkovits M, Roubos E. 2008. Gender-related urocortin 1 and brain-derived neurotrophic factor expression in the adult human midbrain of suicide victims with major depression. Neuroscience. 152 4: 1015–1023.
   PubMed Web of Science ®Google Scholar
• Kozicz T, Bittencourt JC, May PJ, Reiner A, Gamlin PDR, Palkovits M, Horn AKE, Toledo CA, Ryabinin AE. The Edinger–Westphal nucleus: A historical, structural and functional perspective on a dichotomous terminology. J Comp Neurol. 2011 Accepted manuscript online: 23 December 2010 11:00AM EST DOI: 10.1002/cne.22580.
   PubMedGoogle Scholar
• Kudielka BM, Kirschbaum C. 2005. Sex differences in HPA axis responses to stress: a review. Biol Psychol. 69 1: 113–32.
   PubMed Web of Science ®Google Scholar
• Lanteri-Minet M, Isnardon P, de PJ, Menetrey D. 1993. Spinal and hindbrain structures involved in visceroception and visceronociception as revealed by the expression of Fos, Jun and Krox-24 proteins. Neuroscience. 55 3: 737–753.
   PubMedGoogle Scholar
• Lefkowitz RJ, Shenoy SK. 2005. Transduction of receptor signals by beta-arrestins. Science. 308 5721: 512–517.
   PubMed Web of Science ®Google Scholar
• Legendre A, Papakonstantinou E, Roy MC, Richard D, Harris RB. 2007. Differences in response to corticotropin-releasing factor after short- and long-term consumption of a high-fat diet. Am J Physiol Regul Integr Comp Physiol. 293 3: R1076–R1085.
   Google Scholar
• Linden AM, Greene SJ, Bergeron M, Schoepp DD. 2004. Anxiolytic activity of the MGLU2/3 receptor agonist LY354740 on the elevated plus maze is associated with the suppression of stress-induced c-Fos in the hippocampus and increases in c-Fos induction in several other stress-sensitive brain regions. Neuropsychopharmacology. 29 3: 502–513.
   PubMedGoogle Scholar
• Linden AM, Baez M, Bergeron M, Schoepp DD. 2006. Effects of mGlu2 or mGlu3 receptor deletions on mGlu2/3 receptor agonist (LY354740)-induced brain c-Fos expression: Specific roles for mGlu2 in the amygdala and subcortical nuclei, and mGlu3 in the hippocampus. Neuropharmacology. 51 2: 213–228.
   PubMedGoogle Scholar
• Lowery EG, Thiele TE. 2010. Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism. CNS Neurol Disord Drug Targets. 9 1: 77–86.
   PubMedGoogle Scholar
• Mitra SW, Hoskin E, Yudkovitz J, Pear L, Wilkinson HA, Hayashi S, Pfaff DW, Ogawa S, Rohrer SP, Schaeffer JM, McEwen BS, Alves SE. 2003. Immunolocalization of estrogen receptor beta in the mouse brain: Comparison with estrogen receptor alpha. Endocrinology. 144 5: 2055–2067.
   PubMed Web of Science ®Google Scholar
• Morimoto M, Morita N, Ozawa H, Yokoyama K, Kawata M. 1996. Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: An immunohistochemical and in situ hybridization study. Neurosci Res. 26 3: 235–269.
   PubMed Web of Science ®Google Scholar
• Nemeroff CB. 1988. The role of corticotropin-releasing factor in the pathogenesis of major depression. Pharmacopsychiatry. 21 2: 76–82.
   PubMedGoogle Scholar
• Neufeld-Cohen A, Evans AK, Getselter D, Spyroglou A, Hill A, Gil S, Tsoory M, Beuschlein F, Lowry CA, Vale W, Chen A. 2009. Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits. Mol Psychiatry. 15 4: 426–41.
   PubMedGoogle Scholar
• Ohata H, Suzuki K, Oki Y, Shibasaki T. 2000. Urocortin in the ventromedial hypothalamic nucleus acts as an inhibitor of feeding behavior in rats. Brain Res. 861 1: 1–7.
   PubMedGoogle Scholar
• Palkovits M, Sebekova K, Gallatz K, Boor P, Sebekova KJr, Klassen A, Bahner U, Heidland A. 2009. Neuronal activation in the CNS during different forms of acute renal failure in rats. Neuroscience. 159 2: 862–882.
   PubMedGoogle Scholar
• Pan W, Kastin AJ. 2008. Urocortin and the brain. Prog Neurobiol. 84 2: 148–156.
   PubMed Web of Science ®Google Scholar
• Pan W, Tu H, Hsuchou H, Daniel J, Kastin AJ. 2007. Unexpected amplification of leptin-induced Stat3 signaling by urocortin: Implications for obesity. J Mol Neurosci. 33 3: 232–238.
   PubMedGoogle Scholar
• Reul JM, Holsboer F. 2002. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol. 2 1: 23–33.
   PubMedGoogle Scholar
• Romeo RD, Karatsoreos IN, Jasnow AM, McEwen BS. 2007. Age- and stress-induced changes in corticotropin-releasing hormone mRNA expression in the paraventricular nucleus of the hypothalamus. Neuroendocrinology. 85 4: 199–206.
   PubMed Web of Science ®Google Scholar
• Rotimi CN, Comuzzie AG, Lowe WL, Luke A, Blangero J, Cooper RS. 1999. The quantitative trait locus on chromosome 2 for serum leptin levels is confirmed in African–Americans. Diabetes. 48 3: 643–644.
   PubMedGoogle Scholar
• Ryabinin AE, Weitemier AZ. 2006. The urocortin 1 neurocircuit: Ethanol-sensitivity and potential involvement in alcohol consumption. Brain Res Brain Res Rev. 52 2: 368–380.
   Google Scholar
• Ryabinin AE, Tsivkovskaia NO, Ryabinin SA. 2005. Urocortin 1-containing neurons in the human Edinger–Westphal nucleus. Neuroscience. 134 4: 1317–1323.
   PubMedGoogle Scholar
• Scott MM, Lachey JL, Sternson SM, Lee CE, Elias CF, Friedman JM, Elmquist JK. 2009. Leptin targets in the mouse brain. J Comp Neurol. 514 5: 518–532.
   PubMed Web of Science ®Google Scholar
• Selye H. 1951. The general-adaptation-syndrome. Annu Rev Med. 2:327–342.
   PubMed Web of Science ®Google Scholar
• Skelton KH, Owens MJ, Nemeroff CB. 2000. The neurobiology of urocortin. Regul Pept. 93 1–3: 85–92.
   PubMedGoogle Scholar
• Skelton KH, Nemeroff CB, Owens MJ. 2004. Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expression. J Neurosci. 24 42: 9303–9312.
   PubMedGoogle Scholar
• Spangler E, Cote DM, Anacker AM, Mark GP, Ryabinin AE. 2009. Differential sensitivity of the perioculomotor urocortin-containing neurons to ethanol, psychostimulants and stress in mice and rats. Neuroscience. 160 1: 115–125.
   PubMedGoogle Scholar
• Spina M, Merlo-Pich E, Chan RK, Basso AM, Rivier J, Vale W, Koob GF. 1996. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science. 273 5281: 1561–1564.
   PubMed Web of Science ®Google Scholar
• Turek VF, Ryabinin AE. 2005. Expression of c-Fos in the mouse Edinger–Westphal nucleus following ethanol administration is not secondary to hypothermia or stress. Brain Res. 1063 2: 132–139.
   PubMedGoogle Scholar
• Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE. 2000. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol. 428 2: 191–212.
   PubMed Web of Science ®Google Scholar
• Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C. 1995. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 378 6554: 287–292.
   PubMed Web of Science ®Google Scholar
• Vetter DE, Li C, Zhao L, Contarino A, Liberman MC, Smith GW, Marchuk Y, Koob GF, Heinemann SF, Vale W, Lee KF. 2002. Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior. Nat Genet. 31 4: 363–369.
   PubMed Web of Science ®Google Scholar
• Viau V, Sawchenko PE. 2002. Hypophysiotropic neurons of the paraventricular nucleus respond in spatially, temporally, and phenotypically differentiated manners to acute vs. repeated restraint stress: Rapid publication. J Comp Neurol. 445 4: 293–307.
   PubMedGoogle Scholar
• Vilpoux C, Warnault V, Pierrefiche O, Daoust M, Naassila M. 2009. Ethanol-sensitive brain regions in rat and mouse: A cartographic review, using immediate early gene expression. Alcohol Clin Exp Res. 33 6: 945–969.
   PubMedGoogle Scholar
• Wang L, Martinez V, Rivier JE, Tache Y. 2001. Peripheral urocortin inhibits gastric emptying and food intake in mice: Differential role of CRF receptor 2. Am J Physiol Regul Integr Comp Physiol. 281 5: R1401–R1410.
   PubMed Web of Science ®Google Scholar
• Wang X, Su H, Copenhagen LD, Vaishnav S, Pieri F, Shope CD, Brownell WE, De BM, Paylor R, Bradley A. 2002. Urocortin-deficient mice display normal stress-induced anxiety behavior and autonomic control but an impaired acoustic startle response. Mol Cell Biol. 22 18: 6605–6610.
   PubMed Web of Science ®Google Scholar
• Weitemier AZ, Ryabinin AE. 2005. Lesions of the Edinger–Westphal nucleus alter food and water consumption. Behav Neurosci. 119 5: 1235–1243.
   PubMedGoogle Scholar
• Weninger SC, Dunn AJ, Muglia LJ, Dikkes P, Miczek KA, Swiergiel AH, Berridge CW, Majzoub JA. 1999. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc Natl Acad Sci USA. 96 14: 8283–8288.
   PubMedGoogle Scholar
• Weninger SC, Peters LL, Majzoub JA. 2000. Urocortin expression in the Edinger–Westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency. Endocrinology. 141 1: 256–263.
   PubMedGoogle Scholar
• Xu L, Bloem B, Gaszner B, Roubos EW, Kozicz T. 2009. Sex-specific effects of fasting on urocortin 1, cocaine- and amphetamine-regulated transcript peptide and nesfatin-1 expression in the rat Edinger–Westphal nucleus. Neuroscience. 162 4: 1141–1149.
   PubMedGoogle Scholar
• Xu L, Bloem B, Gaszner B, Roubos E, Kozicz T. Stress-related changes in the activity of cocaine- and amphetamine-regulated transcript and nesfatin neurons in the midbrain non-preganglionic Edinger–Westphal nucleus in the rat. Neuroscience. 2010a; 170 2: 478–488.
   PubMedGoogle Scholar
• Xu L, Scheenen WJJM, Leshan RL, Patterson CM, Elias CF, Bouwhuis S, Roubos EW, Myers MJJ, Kozicz T. Evidence that leptin signaling modulates the activity of stress-sensitive urocortin 1 neurons in the non-preganglionic Edinger–Westphal nucleus in the mouse. Endocrinology. 2010b; 152 3: 979–988.
   Google Scholar
• Zalutskaya AA, Arai M, Bounoutas GS, Abou-Samra AB. 2007. Impaired adaptation to repeated restraint and decreased response to cold in urocortin knockout mice. Am J Physiol Endocrinol Metab. 293:E259–E263.
   Google Scholar